Related Experiment Video
Updated: Jun 10, 2026

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
Published on: January 29, 2011
Quetiapine-induced hyperventilation and dyspnea.
Jochen Mutschler1, Caitriona Obermann, Martin Grosshans
1Department of General and Social Psychiatry, Psychiatric University Hospital Zurich, Zurich, Switzerland. jochen.mutschler@puk.zh.ch
This case report details a patient with bipolar disorder experiencing quetiapine-induced hyperventilation. Prompt dosage reduction and switching antipsychotics are recommended for respiratory symptoms.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Quetiapine, an atypical antipsychotic, is effective for bipolar disorder.
- Recent reports link quetiapine to respiratory dysfunction.
Observation:
- A case of quetiapine-induced hyperventilation and dyspnea in a bipolar disorder patient is presented.
- This is the first reported instance of quetiapine-induced hyperventilation in this patient population.
Findings:
- Quetiapine treatment can precipitate respiratory symptoms like hyperventilation and dyspnea.
- The mechanism of quetiapine-induced respiratory dysfunction requires further investigation.
Implications:
- Clinicians should monitor for respiratory symptoms in patients taking quetiapine.
- Consider rapid quetiapine dose reduction and antipsychotic switching if unexplained respiratory symptoms occur.
Related Concept Videos
Hyperpnea and Hyperventilation
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes include...
Acute Respiratory Failure-III
Acute Respiratory Failure-IV
Respiratory Volumes and Capacities I
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
